REBIF (EMD Serono, Inc.)


Welcome to the PulseAid listing for the REBIF drug offered from EMD Serono, Inc.. This Interferon-beta [Chemical/Ingredient],Recombinant Human Interferon beta [EPC],Recombinant Proteins [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: EMD Serono, Inc.
NON-PROPRIETARY NAME: INTERFERON BETA-1A
SUBSTANCE NAME: INTERFERON BETA-1A
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Interferon-beta [Chemical/Ingredient],Recombinant Human Interferon beta [EPC],Recombinant Proteins [Chemical/Ingredient]
ROUTE: SUBCUTANEOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: BLA
START MARKETING DATE: 2002-03-07
END MARKETING DATE: 0000-00-00


REBIF HUMAN PRESCRIPTION DRUG Details:

Item DescriptionREBIF from EMD Serono, Inc.
LABELER NAME: EMD Serono, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 22(ug/.5mL)
START MARKETING DATE: 2002-03-07
END MARKETING DATE: 0000-00-00
PRODUCT ID: 44087-0022_a0782365-7987-4882-94f7-20bd85e40401
PRODUCT NDC: 44087-0022
APPLICATION NUMBER: BLA103780

Other INTERFERON BETA-1A Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
EMD Serono, Inc.REBIF